ArticleJAMA otolaryngology-- head & neck surgery2025
Retractions in Otolaryngology Publications.
Article in JAMA otolaryngology-- head & neck surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Retractions of publications on central nervous system tumors based on the Retraction Watch Database.Chinese neurosurgical journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To characterize trends in otolaryngology (ear, nose, and throat [ENT]) retractions, identify underlying causes, and compare retraction rates with similar specialties. Design, Setting, and Participants: A scoping review of retracted articles published from January 1, 1974, through December 31, 2023, was carried out. Retraction data were obtained from the Crossref/Retraction Watch database and corresponding abstracts were retrieved from PubMed. Publication data were obtained from Scopus. All retracted articles related to ENT were identified. Articles from neurosurgery and ophthalmology were similarly retrieved for comparison. Articles withdrawn for routine updates, expressions of concern, reinstatements, and corrections were excluded. The data were obtained on December 3, 2024. Main Outcomes and Measures: The primary outcomes were annual retraction rate (proportion of retracted articles per total published articles) and reasons for retraction (categorized as intentional data misconduct, intentional procedural misconduct, unintentional data errors, unintentional procedural errors, or unknown). Secondary measures included time from publication to retraction and comparisons with neurosurgery and ophthalmology retraction rates. Results: Of 481 215 ENT articles, 471 (0.10%) were retracted. Retractions increased over time, peaking in 2022 with a retraction rate of 0.42%. Among retracted ENT articles, the most common reasons were intentional data misconduct (233 [49.50%]) and intentional procedural misconduct (210 [44.60%]). Articles with first authors from China accounted for the largest share (243 [51.60%]) of these retractions. Basic science head and neck cancer research represented the largest subspecialty category (161 [34.20%]). The median (IQR) time to retraction was 21.8 (10.8-55.3) months. Conclusions and Relevance: This analysis found that retractions in ENT literature have increased over 5 decades, predominantly driven by intentional misconduct. These findings highlight the need for enhanced oversight, training, and editorial vigilance to maintain the integrity of ENT research and protect patient welfare.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.